Insmed
INSM
#752
Rank
A$46.84 B
Marketcap
A$213.52
Share price
-2.17%
Change (1 day)
-32.35%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2026 (TTM): -A$0.77 Billion

According to Insmed's latest financial reports the company's current earnings are A$1.51 Billion. In 2025 the company made an earning of -A$1.81 Billion a decrease over its 2024 earnings that were of -A$1.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.77 Billion-57.37%
2025 -A$1.81 Billion43.91%
2024 -A$1.26 Billion23.71%
2023 -A$1.02 Billion45.77%
2022 -A$0.7 Billion15.83%
2021 -A$0.61 Billion50.19%
2020 -A$0.4 Billion16.4%
2019 -A$0.35 Billion-23.9%
2018 -A$0.46 Billion59.35%
2017 -A$0.29 Billion8.52%
2016 -A$0.27 Billion47.25%
2015 -A$0.18 Billion34.53%
2014 -A$0.14 Billion58.83%
2013 -A$82.92 Million35.14%
2012 -A$61.36 Million-31.92%
2011 -A$90.13 Million854.92%
2010 -A$9.44 Million-105.22%
2009 A$0.18 B-905.06%
2008 -A$22.45 Million-27.31%
2007 -A$30.88 Million-62.41%
2006 -A$82.15 Million98.19%
2005 -A$41.45 Million0.03%
2004 -A$41.44 Million159.07%
2003 -A$16 Million-69.31%
2002 -A$52.11 Million
2000 -A$46.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$19.10 B-2,520.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
-A$3.83 Billion 384.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$6.89 B-973.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-A$0.2 Billion-74.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-A$35.12 Million-95.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-A$78.04 Million-90.11%๐Ÿ‡บ๐Ÿ‡ธ USA